AndhraNews.net
Home » Features » Health » Open Heart Surgery

Open Heart Surgery


About Open Heart Surgery

Open Heart Surgery in News

NMT II Live PFO Closure Creates Stir at Global Meeting of Cardiologists
For the first time in the company's history, NMT II announces that a Live case was successfully performed on camera, and transmitted in real time to the Congress for CSI -- attended by over 1,100 of the world's top cardiologist and physicians. A video of the case can be seen at http://www.csi-congress.org/?go=605.

East Alabama Medical Center Chooses Velocity Technology Solutions for Infor 10 Application Management Services
CHARLOTTE, NC--(Marketwired - December 08, 2015) - Velocity Technology Solutions, a global leader in enterprise and business application cloud services, today announced that it has added East Alabama Medical Center (EAMC) to its growing community of Infor / Lawson system customers.

Symetis Reaches Key Milestone-1000 Patients Treated with ACURATE neo(TM) Aortic Heart Valve
Symetis SA, a medical technology company ("Symetis"), announced today that less than a year after its commercial launch its state-of-the-art transcatheter aortic valve, ACURATE neo/TF, has been implanted in more than 1000 patients. Symetis's ACURATE TA system, launched in 2011, has achieved a number two position in its segment of the European TAVI market.

HeartStitch(R) Brings New Technology to Astana to Treat Structural Heart Disease
Specialists of the National Research Cardiac Surgery Center (NRCSC) in Astana, Kazakhstan together with Dr. Michael Mullen, and with the guidance of Professor Anthony A. Nobles, performed a new, minimally invasive procedure to close the Patent Foramen Ovale (PFO) of the heart using the NobleStitch EL device for cardiovascular suturing

Improving Member Health Leads to Reduction in Costs: Achieving the Triple Aim
NEW YORK, NY--(Marketwired - April 23, 2015) - Cammack Health shows industry-leading results in a white paper, Achieving the Triple Aim: How One Health Care Group Reduced Costs and Improved Member Health, released today.

Sentara Healthcare Takes on America's Deadliest Disease
Overview Campaign focused on raising awareness of heart disease among men and women. Focus is on disease prevention through a heart-healthy lifestyle. Unique activities draw attention to the issue in a positive, uplifting way. The Sentara Healthcare 28 Days of Heart campaign may be coming to an end, but taking care of your heart is a lifelong endeavor

Jean Boulle Group - US$250 Million+ Abbott Laboratories Acquisition of Tendyne Holdings Mitral Valve Company Confirms the Group’s Pedigree for Making Serial Major Discoveries from Mines to Medical technology.
Business Wire IndiaJeanBoulle Medtech Ltd, a Jean Boulle Group (www.jeanboullegroup.com) medical technology company and founding investor of Tendyne Holdings, Inc. ("Tendyne"), is pleased to announce that Abbott Laboratories (NYSE: ABT) has closed its acquisition of Tendyne (www.tendyne.com)

Jean Boulle Group Announces First US Clinical Trial
Business Wire IndiaBoulle Medtech Ltd, a Jean Boulle Group medical technology company and the founding investor of Tendyne Holdings, Inc. ("Tendyne"), is pleased to announce that the Tendyne Transcatheter Mitral Valve Implant (TMVI) was successfully implanted in the first patient in the United States.

MedStar Heart & Vascular Institute Increases Regional Cardiovascular Presence as MedStar Union Memorial Hospital Enters Unique Alliance With Cleveland Clinic
MedStar Heart & Vascular Institute at MedStar Union Memorial Hospital announced today it has entered into a groundbreaking clinical and research alliance with the world renowned Cleveland Clinic Sydell and Arnold Miller Family Heart & Vascular Institute.

First Synthetic Human Cadaver Lab on US West Coast Opens at Stanbridge College
Stanbridge College, a private college that offers Master, Bachelor, and Associate of Science degree and diploma programs in Healthcare and Information Technology, has opened the first Synthetic Human Cadaver Lab on the West Coast as a training resource for its students

Dr. Patino to Present at the 9th Annual American Society of Cosmetic Physicians
Dr. Gabriel Patino from El Cerrito, California will present at the 9th Annual American Society of Cosmetic Physicians (ASOCP) conference being held in Scottsdale, Arizona this week. This five-day conference offers lectures from leaders in the field of cosmetic surgery and they asked Dr

Symetis Receives CE Mark Approval for Transfemoral Transcatheter Aortic Heart Valve System ACURATE neo(TM), and Launches Product With First Commercial Implantations
Symetis SA, the leading European developer of transcatheter aortic valve implantation (TAVI) systems, announced today the launch of ACURATE neo™, its 15F compatible transfemoral TAVI system. Commercial implantations started early September after Symetis received CE Mark approval for ACURATE neo this summer.

Enguity Commends Cigna After Shocking Special Needs Family, Commits to Global Change
Enguity commends Cigna, a globally recognized health insurer, after it shocked special needs family Kraig and Jennipher Beahn by referring to their newborn, Kennedi Beahn, as "mentally retarded." The family immediately sprang into action, advocating on behalf of their own daughter as well as all other special needs families

Janet and Paul J. Burt of WestLake Financial Group, Inc. Lead American Heart Association to Record Donation Level for Chicago Heart Ball
WestLake Financial Group, Inc., a recognized leader in voluntary benefits, HR consulting, and employee benefits technology is pleased to announce the record breaking results of the 2014 American Heart Association's Chicago Heart Ball. Paul J. Burt, founder and CEO of WestLake Financial Group and co-founder of Cera Solutions, along with his wife, Janet, were the chairs of this year's event.

Mark Elfstrand Joins AM 1160 WYLL as Afternoon Host
Salem Communications Corporation (NASDAQ: SALM) announced today that beginning May 20, 2014, Mark Elfstrand will join AM 1160 WYLL as the host of "Let's Talk with Mark Elfstrand," heard weekday afternoons from 4-6pm.

Bioheart Reports Positive Update on CEO Mike Tomas
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cellular therapies, reports that Mike Tomás, President and CEO, is recovering well and as planned from his emergency open-heart surgery.

Edwards' SAPIEN XT Valve Approved in Europe for Transcatheter Mitral and Aortic Valve-in-Valve Procedures

CytoSorbents to Exhibit at the 43rd Annual Meeting of the German Society for Thoracic, Heart and Vascular Surgery
CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company, announced that it will exhibit at the 43rd Annual Meeting of the German Society for Thoracic, Heart and Vascular Surgery in Freiburg, Germany from February 9-12, 2014. The conference is in cooperation with the Austrian and Swiss Societies for Thoracic and Cardiovascular Surgery.

Children's HeartLink Develops Pre- and Post-Operative Care Instructions for Caregivers of Children With Congenital Heart Disease
Children's HeartLink, a nonprofit organization promoting sustainable cardiac care for children in developing countries, announced today that they have created and released publicly Parent Education/Discharge Instructions (PEDI) to help educate caregivers on pre- and post-operative care for children who have undergone open-heart surgery.

Diabetic Patients at High Risk for Aortic Valve Surgery Experienced Lower All-Cause Mortality When Treated With SAPIEN Valve

Free Seminar on Robotic Hysterectomy at Methodist Willowbrook Hospital Highlights Benefits of Minimally Invasive Surgery
HOUSTON, TX--(Marketwire - March 28, 2013) - Members of the community are invited to attend a free seminar on Robotic Hysterectomy: A New Experience in Minimally Invasive Surgery hosted by Methodist Willowbrook Hospital. The lecture is presented by Chuong H. Pham, M.D., board certified obstetrician/gynecologist, Tuesday, April 2 from 6:00 to 7:30 p.m

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced the three-year results of a pivotal clinical study of severe aortic stenosis patients at high-risk for surgery. The results continue to demonstrate comparable outcomes between treatment with the Edwards SAPIEN transcatheter heart valve and open-heart surgery

The Medicines Company's Intravenous Cangrelor Demonstrates 22% Reduction in Ischemic Events Compared to Oral Clopidogrel
The Medicines Company (NASDAQ: MDCO) today reported results of CHAMPION PHOENIX, a 11,145 patient Phase 3 randomized, double-blind clinical trial comparing the Company's intravenous antiplatelet cangrelor to oral clopidogrel in patients undergoing percutaneous coronary intervention (PCI). Patients treated with cangrelor had a 22% (p=0

Lower-Profile SAPIEN XT Transcatheter Heart Valve Associated With Improved Procedural Outcomes

One Heart Surgery – Saves the Lives of Two
-- A path breaking heart surgery ‘Pumpless & Bloodless’ on 31 year old pregnant lady from Iraq was performed here at Global Health City using a “Double Disc ASD” device through a KEYHOLE approach. -- She has recuperated well and can now look forward to a normal life with her happy family & the awaited bundle of joy. A 31-year-old Ms

Heart Center at Missouri Baptist Chosen as One of Few in U.S. to Perform Transcatheter Aortic Valve Replacement (TAVR) Through the Ribs -- Allows Aortic Valve Replacement Without Surgery for High Risk Patients Not Otherwise Eligible for Treatment
Missouri Baptist Medical Center has been chosen as one of the few heart centers in the U.S. approved to offer transcatheter aortic valve replacement (TAVR) to treat high risk aortic stenosis patients by implanting a new valve either through the ribs or via an artery in the groin, without open-heart surgery.

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced three-year results of a pivotal clinical study of inoperable patients with severe aortic stenosis treated with the Edwards SAPIEN transcatheter heart valve

FDA Approves Expanded Indication for Edwards Lifesciences' Transcatheter Valve

New Approach to Valve Replacement Gives Patients a Second Chance
A new heart valve procedure treating aortic stenosis is not only saving lives, but can make patients feel years younger. Missouri Baptist Medical Center in St. Louis was recently approved to be one of the few centers in the country to offer transcatheter aortic valve replacement (TAVR).

Armed with Impressive Partnerships, Can This Emerging Innovator Become 2012's Most Successful Medical Device IPO?
Image-guided surgery has revolutionized the accuracy and cost of performing surgery - creating minimally-invasive procedures that allow patients quicker recovery and save clinics, physicians, patients, and health insurers time and money.Fluoroscopy, for example, created a non-invasive alternative to open-heart surgery, with an estimated 1.5MM procedures performed annually

FDA Panel Recommends Approval of Edwards Transcatheter Valve for High-Risk Patients
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced today that a U.S

Strong Two-Year Outcomes Reported for High-Risk Transcatheter Patients

Methodist Willowbrook Hospital Achieves American Nurses Credentialing Center "Pathway to Excellence(R)" Designation
Methodist Willowbrook Hospital is pleased to announce it has achieved "Pathway to Excellence®" designation by the American Nurses Credentialing Center (ANCC).

Substantial New Transcatheter Patient Data Presented at STS
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced today that new data were presented on high-risk surgical patients with severe aortic stenosis treated with transapical transcatheter aortic valve replacement (TAVR) during the continued access period of Cohort A of The PARTNER Trial

Australians in world's 1st major heart valve breakthrough surgery
A new treatment to replace a major heart valve in patients could be widely available in two years after the first successful trial conducted by Australian surgeons.

3-year-old boy world's first to survive being born with heart outside body
A boy in US, who was born with his heart outside his body, is world's first child to survive under such circumstances.

Heart surgery on baby aged just 17 hours sets world record
A tiny fighter from UK is recovering in hospital after becoming the youngest person to have open-heart surgery.

Newborn girl at 3lb 5oz is smallest baby to undergo open-heart surgery in UK
A baby girl who was born prematurely weighing just 3lb 5oz with a serious heart condition that left her struggling to breathe, has become the smallest baby to undergo open heart surgery in Britain.

Oz mom who died for 12 mins after heart attack comes back to life
An Australian mother who was left brain dead for up to 12 minutes after heart attack has surprised doctors by surviving from the cardiac arrest with no brain damage.

Breakthrough 90-minute treatment to replace valve sans open-heart surgery
Heart valve replacement without open-heart surgery could offer a new option for patients with aortic stenosis who are at high-risk or are considered inoperable, according to a new research.

New device uses submarine technology to detect stroke quickly
A medical device developed by retired US Navy sonar experts, using submarine technology, has become the new idea for the detection, diagnosis and monitoring of stroke.

Cardiac rehab 'can improve heart patients' quality of life'
Researchers at the Peter Munk Cardiac Centre have said that healthcare practitioners can increase the number of patients with heart disease referred to a cardiac rehabilitation program by 40 per cent, helping them to reduce their risk of dying and improve their quality of life.

Fixing hearts without open-heart surgery
Until now, pulmonary valve replacements have required open-heart surgery.

Early Clinical Experience With EDWARDS INTUITY Valve System Demonstrates Promise of New Technology
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced that interim data from a multi-center European prospective study of the investigational EDWARDS INTUITY Valve System showed promising results for patients undergoing surgical aortic valve replacement (AVR)

Edwards Lifesciences Achieves Primary Endpoint in Transcatheter Valve Study of High-Risk Surgical Patients
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced the results of a pivotal clinical study of high-risk surgical patients with severe aortic stenosis treated in Cohort A of The PARTNER Trial

Clinical and Economic Data From The PARTNER Trial to Be Presented at ACC 2011
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that one-year clinical outcomes from Cohort A of The PARTNER Trial are scheduled to be presented at 9:15 a.m. CT on Sunday, April 3, at the American College of Cardiology's (ACC) 60th Annual Scientific Session & Expo in New Orleans, La

Veteran Bollywood actor Bob Christo passes away
Veteran Bollywood actor Bob Christo, who essayed the role of a villain in films of the eighties and nineties, passed away here on Sunday afternoon. He was 70.

Comment on this story

Share